Anti-IGF2 antibody [EPR12221]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Recombinant Monoclonal IGF2 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 8 publications.
View Alternative Names
IGF-2, PP1446, IGF2, Insulin-like growth factor 2, Insulin-like growth factor II, Somatomedin-A, T3M-11-derived growth factor, IGF-II
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-IGF2 antibody [EPR12221] (AB177467)
Immunofluorescence analysis of HepG2 cells labeling IGF2 (green) with ab177467 at 1/50 dilution. DAPI nuclear staining (blue).
- WB
Supplier Data
Western blot - Anti-IGF2 antibody [EPR12221] (AB177467)
All lanes:
Western blot - Anti-IGF2 antibody [EPR12221] (ab177467) at 1/1000 dilution
All lanes:
Human serum lysate at 10 µg
Secondary
All lanes:
Goat-anti-rabbit HRP at 1/2000 dilution
Predicted band size: 20 kDa
true
Related conjugates and formulations (2)
-
Anti-IGF2 antibody [EPR12221] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-IGF2 antibody [EPR12221]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
World journal of gastrointestinal oncology 16:3585-3599 PubMed39171181
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e29682 PubMed38707418
2024
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 18:20230751 PubMed37693837
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:922465 PubMed36568212
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of gynecologic oncology 33:e75 PubMed36245227
2022
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica Polonica 69:349-355 PubMed35617351
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 20:1561-1577 PubMed34313533
2021
Applications
Unspecified application
Species
Unspecified reactive species
European review for medical and pharmacological sciences 21:1803-1809 PubMed28485799
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com